Intra-Cellular Therapies Inc. (ITCI) Social Stream



Intra-Cellular Therapies Inc. (ITCI): $52.09

1.71 (-3.18%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ITCI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#36 of 359

in industry

INTRA-CELLULAR THERAPIES INC (ITCI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering INTRA-CELLULAR THERAPIES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 7 $70 $45 $53 $54.36 -2.5%
2021-12-06 7 $70 $45 $53.428 $54.36 -1.71%
2021-12-20 7 $85 $46 $56.666 $54.36 4.24%
2021-12-21 7 $85 $46 $59.285 $54.36 9.06%
2022-01-06 7 $85 $46 $59.428 $54.36 9.32%
2022-01-23 7 $85 $46 $60 $54.36 10.38%
2022-01-28 7 $85 $46 $60.142 $54.36 10.64%
2022-03-02 7 $90 $49 $64.285 $54.36 18.26%
2022-03-08 7 $90 $55 $65.142 $54.36 19.83%
2022-04-13 7 $90 $55 $65.857 $54.36 21.15%
2022-04-21 8 $90 $55 $66.571 $54.36 22.46%
2022-05-11 9 $90 $55 $66.75 $54.36 22.79%
2022-05-16 9 $90 $55 $66.555 $54.36 22.43%
2022-06-14 10 $90 $55 $67.4 $54.36 23.99%
2022-08-09 11 $90 $55 $67.545 $54.36 24.25%
2022-08-15 11 $90 $57 $69.727 $54.36 28.27%
2022-10-13 11 $90 $49 $68.363 $54.36 25.76%
2022-11-03 11 $90 $49 $67.636 $54.36 24.42%
2022-11-04 11 $90 $49 $67.818 $54.36 24.76%
2023-02-08 11 $93 $49 $70.083 $54.36 28.92%
2023-02-13 11 $93 $49 $70.5 $54.36 29.69%
2023-03-01 11 $93 $49 $70.916 $54.36 30.46%
2023-03-02 11 $93 $49 $70.75 $54.36 30.15%
2023-03-28 11 $93 $49 $70.666 $54.36 30%
2023-03-29 12 $93 $49 $70.666 $54.36 30%
2023-04-05 12 $98 $49 $71.666 $54.36 31.84%
2023-04-17 12 $98 $49 $72 $54.36 32.45%
2023-05-04 13 $98 $49 $72.615 $54.36 33.58%
2023-05-08 13 $98 $49 $74.153 $54.36 36.41%
2023-06-06 13 $98 $49 $74.461 $54.36 36.98%
2023-06-30 11 $98 $49 $75.916 $54.36 39.65%
2023-08-03 11 $98 $49 $76.5 $54.36 40.73%
2023-08-04 10 $98 $59 $79.909 $54.36 47%

The Trend in the Analyst Price Target


ITCI's average price target has moved up $11.33 over the prior 16 months.

Over the past 42 weeks, ITCI's average upside potential has been 31.55%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-10-26 11 90 49 67.636 45.93 47.26%
2023-03-09 11 93 49 70.666 44.24 59.73%
2023-04-17 12 98 49 72.000 63.18 13.96%
2023-06-06 13 98 49 75.545 65.41 15.49%
2023-06-30 11 98 49 75.916 63.32 19.89%

ITCI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 7 2 1 0 0 10

The Trend in the Broker Recommendations


ITCI's average broker recommendation rating worsened by 0.19 over the prior 13 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ITCI as an investment opportunity.

  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, INTRA-CELLULAR THERAPIES INC's upside potential (average analyst target price relative to current price) is higher than 935.79% of them.
  • ITCI has a higher average analyst price target than 3667.5% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, INTRA-CELLULAR THERAPIES INC's number of analysts covering the stock is greater than 3303.89% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, INTRA-CELLULAR THERAPIES INC's variance in analysts' estimates is lower than -3109.88% of them.

In the Pharmaceutical Products industry, PRTA, IRWD, and AGIO are the three stocks most similar to INTRA-CELLULAR THERAPIES INC regarding the price target and analyst recommendation information presented here.

Is ITCI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!